• de
    • en
  • Viral Infections
    • COVID-19
    • MERS-CoV
    • Ebola
    • Hepatitis
    • HIV / AIDS
    • Influenza
    • Varizella zoster
  • Bacterial Infections
    • Bakterielle Infektionen bei Cystischer Fibrose
    • Blutstrominfektionen
    • Bronchiektasen
    • Clostridium difficile Infektionen
      • Cadazolid/ ACT-179811 (AC-0641A301)

        A multi-center, randomized, double-blind study to compare the efficacy and safety of cadazolid versus vancomycin in subjects with Clostridium difficile-associated diarrhea (CDAD)

      • CDAD und intestinale Mikrobiota

        Multizentrische, prospektive Kohortenstudie zu Mikrobiota-definierten und klinischen Risikofaktoren für eine Kolonisierung mit Clostridium difficile und -assoziierte Erkrankung (CDAD) in Risikokollektiven (Cadazolid /ACT-179811 (AC-0641A301))

      • LCD-CDAD-10-07 (CUBIST)

        A Randomized, Double-Blinded, Active-Controlled Study of Surotomycin (CB-183,315) in Patients with Clostridium difficile Associated Diarrhea

      • MicroTrans

        A multicenter registry for fecal microbiota transfer

      • MODIFY I

        A Phase III, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study of the Efficacy, Safety, and Tolerability of a Single Infusion of MK-3415 (Human Monoclonal Antibody to Clostridium difficile toxin A), MK-6072 (Human Monoclonal Antibody to Clostridium difficile toxin B), and MK-3415A (Human Monoclonal Antibodies to Clostridium difficile toxin A and toxin B) in Patients Receiving Antibiotic Therapy for Clostridium difficile Infection (MODIFY I)

    • ESBL
    • Harnwegsinfektion
    • Pneumonien
  • Infektionen bei Immungeschwächten Patienten
  • Invasive Pilzinfektionen
  • Gastrointestinale Infektionen
© 2025 Healex GmbH Legal notice Privacy